Results 111 to 120 of about 25,133 (198)

Evaluation of the Safety, Efficacy and Pharmacokinetics of BGM0504 in Chinese Adults With Type 2 Diabetes: A Multicentre, Randomised, Controlled and Double‐Blind Phase II Trial

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 8, Page 7073-7082, August 2026.
ABSTRACT Aim This study aimed to evaluate its safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy in Chinese adults with T2DM and to preliminarily compare its efficacy and safety with semaglutide through multiple subcutaneous injections. Materials and Methods In this multicentre, randomised, placebo‐controlled and semaglutide‐positive‐
Ping Jin   +9 more
wiley   +1 more source

Evaluating Cosmetic Efficacy: A Comparative Study on Methods for Assessing Skin Redness Reduction and Soothing

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 8, August 2026.
ABSTRACT Background The growing population affected by skin redness, driven by environmental changes and lifestyle factors, underscores the need for effective cosmetic solutions. While such products can significantly alleviate physical discomfort and improve psychological well‐being, a lack of standardized technical guidance persists for laboratory ...
Yue Du   +4 more
wiley   +1 more source

Differential Pathophysiological Drivers of Susceptibility to Type 2 Diabetes and Metabolic Dysfunction–Associated Steatotic Liver Disease: Ethnic Differences in Insulin Dynamics, Whole‐Body Fat Metabolism, and Organ‐Specific Lipid Deposition

open access: yesObesity Reviews, Volume 27, Issue 8, August 2026.
ABSTRACT Introduction This narrative review explores the epidemiological evidence and potential underlying pathophysiological defects underlying the disproportionately greater risk of Type 2 diabetes (T2D) and cardiometabolic disease in people of South Asian and African Caribbean ancestry compared with White Europeans.
Daniel J. Cuthbertson   +6 more
wiley   +1 more source

Pancreatic cancer cachexia promotes cardiac dysfunction through altered adrenergic signalling in the heart

open access: yesThe Journal of Physiology, Volume 604, Issue 15, Page 6281-6301, 1 August 2026.
Abstract figure legend The β1‐adrenergic receptor is the predominant adrenergic subtype expressed on cardiac myocytes. Upon stimulation it activates downstream signalling pathways that increase the heart rate and cardiac output to meet metabolic demands.
Parham Diba   +13 more
wiley   +1 more source

Contribution of tissue oximetry to the assessment of renal dysfunction in abdominal compartment syndrome: an experimental canine study. [PDF]

open access: yesFront Surg
Nalbanti V   +11 more
europepmc   +1 more source

Abdominal compartment syndrome in critically ill patients. [PDF]

open access: yesAcute Crit Care, 2023
Jang H   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy